David Clever
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune cells in cancer
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in ⓘ
- Immunology 12
- Immune Cell Function and Interaction 8
- T-cell and B-cell Immunology 4
- Immune cells in cancer 3
- Oncology 10
- CAR-T cell therapy research 4
- Cancer Immunotherapy and Biomarkers 4
- Cytokine Signaling Pathways and Interactions 2
- Co-authors
- Nicholas P. Restifo (11 shared papers)Robert Eil (7 shared papers)Madhusudhanan Sukumar (7 shared papers)Christopher A. Klebanoff (9 shared papers)Douglas C. Palmer (6 shared papers)Rahul Roychoudhuri (8 shared papers)Zhiya Yu (3 shared papers)Jenny H. Pan (3 shared papers)
- Journals
- Journal for ImmunoTherapy of Cancer (4 papers)Blood (2 papers)Journal of Bone and Joint Surgery (2 papers)Cancer Immunology Research (2 papers)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
David Clever
18 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Immunology 778
- Oncology 714
- Cancer Research 190
- Molecular Biology 518
- Hematology 73
Countries citing papers authored by David Clever
This map shows the geographic impact of David Clever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Clever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Clever more than expected).
Fields of papers citing papers by David Clever
This network shows the impact of papers produced by David Clever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Clever. The network helps show where David Clever may publish in the future.
Co-authors
The 25 scholars most cited alongside David Clever, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Ionic immune suppression within the tumour microenvironment limits T cell effector function Hit paper breakdown → | 2016 | 489 |
| 2 | 2016 | 199 | |
| 3 | 2011 | 169 | |
| 4 | 2017 | 160 | |
| 5 | 2015 | 139 | |
| 6 | 2014 | 99 | |
| 7 | 2017 | 51 | |
| 8 | 2014 | 30 | |
| 9 | 1993 | 20 | |
| 10 | 2021 | 14 | |
| 11 | 2022 | 13 | |
| 12 | 2021 | 9 | |
| 13 | 2025 | 4 | |
| 14 | 2021 | 2 | |
| 15 | 2015 | 2 | |
| 16 | 2010 | 2 | |
| 17 | 2015 | 1 | |
| 18 | 2013 | 1 | |
| 19 | 2024 | 0 | |
| 20 | 2015 | 0 |
About David Clever
David Clever is a scholar working on Immunology, Oncology, Molecular Biology, Surgery and Epidemiology, having authored 20 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (8 papers), CAR-T cell therapy research (4 papers), T-cell and B-cell Immunology (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Immune cells in cancer (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Trauma and Emergency Care Studies (2 papers) and Hip and Femur Fractures (2 papers). The work is most often cited by research in Immunology (778 citations), Oncology (714 citations), Cancer Research (190 citations), Molecular Biology (518 citations) and Hematology (73 citations). David Clever has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Nicholas P. Restifo, Robert Eil, Madhusudhanan Sukumar, Christopher A. Klebanoff, Douglas C. Palmer, Rahul Roychoudhuri, Zhiya Yu, Jenny H. Pan, Suman K. Vodnala and Tori N. Yamamoto. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Blood, Journal of Bone and Joint Surgery, Cancer Immunology Research and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.